García Federico, Álvarez Marta, Bernal Carmen, Chueca Natalia, Guillot Vicente
Servicio de Microbiología, Hospital Universitario San Cecilio, Granada, España.
Enferm Infecc Microbiol Clin. 2011 Apr;29(4):297-307. doi: 10.1016/j.eimc.2010.12.006. Epub 2011 Feb 23.
The accurate diagnosis of HIV infection demands that to consider a positive result, at least three assays with different antigenic base should be used, one of them, Western-Blot being mandatory for confirmation. Fourth generation ELISAs shorten the window phase to 13-15 days, as they now include p24 antigen detection. Proviral DNA or Viral RNA detection by molecular methods have proved useful for addressing complex situations in which serology was inconclusive. Viral load (HIV-RNA) is routinely used to follow-up HIV infected patients and is used for treatment initiation decisions. It is also used to monitor viral failure. When this happens, resistance tests are needed to guide treatment changes. Resistance is also used to assess the transmission of drug resistance to newly diagnosed patients. Finally, before using an anti-CCR5 drug, viral tropism needs to be determined. This can be done using genotypic tests, widely available in many HIV labs, or phenotypic tests, only available at certain sites.
准确诊断HIV感染要求,若要认定检测结果为阳性,应至少使用三种基于不同抗原的检测方法,其中必须有一种是用于确认的免疫印迹法。第四代酶联免疫吸附测定(ELISA)将窗口期缩短至13 - 15天,因为现在它们包含p24抗原检测。通过分子方法检测前病毒DNA或病毒RNA已被证明有助于解决血清学检测结果不明确的复杂情况。病毒载量(HIV - RNA)通常用于对HIV感染患者进行随访,并用于决定开始治疗的时机。它也用于监测病毒治疗失败情况。当出现这种情况时,需要进行耐药性检测以指导治疗方案的调整。耐药性检测还用于评估耐药性向新诊断患者的传播情况。最后,在使用抗CCR5药物之前,需要确定病毒嗜性。这可以通过许多HIV实验室广泛使用的基因检测方法,或仅在某些特定地点可用的表型检测方法来完成。